Anal Cancer - 81 Studies Found

Completed : OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
: Cancer
: 2009-05-09
:
  • Genetic: protein expression analysis

Completed : Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
: Cancer
: 1999-11-01
:
  • Drug: capecitabine
  • Radiation: radiation th
Completed : Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
: Cancer
: 2000-05-02
: Drug: aminocamptothecin colloidal dispersion
Completed : High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
: Cancer
: 1999-11-01
:
  • Biological: filgrastim
  • Drug: carboplatin
Active, not recruiting : Cisplatin-based Chemotherapy Combined With P16_37-63 Peptide Vaccination in Patients With HPV-positive Cancers
: HPV-induced Cancers
: 2015-08-10
:
  • Biological: P16_37-63 peptide combined with Montanide® ISA-51 VG

Completed : Care of Cancer Patients With Bowel Injury Caused by Radiation Therapy to the Pelvis
: Cancer
: 2008-08-15
:
  • Other: educational intervention
  • Other: que
NOT_YET_RECRUITING : REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation
:
: 2025-08-07
: 28-30 fractions Monday through Friday of intended chemoradiation depending on the total dose required (50.4-54Gy) which will occur over approxim
Completed : ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIES
: Anal Cancer
: 2025-08-07
: MSM participants will complete a one-time survey, delivered in an e-format.Survey will be accessible via Meta-based social media platforms (Face
Completed : Prebiotics and Probiotics During Definitive Treatment With Chemotherapy-radiotherapy SCC of the Anal Canal (BISQUIT)
: Anal Cancer Squamous Cell
: 2025-08-07
: Administration of prebiotics in combination with probiotics before the start of Ch-RT
COMPLETED : Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management
: Rectal or Anal Cancer
: 2025-08-07
: Patients will receive 3 fractions of endorectal brachytherapy, each spaced apart by 7 days (+/- 1 day).The three dose tiers will be 1500cGy
<<< Previous | Next >>>